CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q3 2021 13F Holders as of 30 Sep 2021

Share change
-393,364
Put/Call ratio
79%
SEC-reported price per share
$5.27
Number of holders
29
Value change
-$2,368,802
Number of buys
13
Open additional details 1 more signal available
Number of sells
12

Security key

23254L603

Report period

Q3 2021

Institutions

29

Top holders

10

Ownership snapshot

Top reported holders of CYCC - CYCLACEL PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SPHERA FUNDS MANAGEMENT LTD.
Disclosed value leader
SPHERA FUNDS MANAGEMENT LTD.
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $3,009,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SPHERA FUNDS MANAGEMENT LTD. has the largest disclosed position value at $3.01M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SPHERA FUNDS MANAGEMENT LTD.'s linked filing trail.
Disclosed position value Top 5
SPHERA FUNDS MANAGEMENT LTD. $3.01M
J. Goldman & Co LP $2.62M
Sio Capital Management, LLC $2.47M
Affinity Asset Advisors, LLC $2.25M
VANGUARD GROUP INC $1.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
13F
—
denominator unverified
$3,009,000
508,322 shares
— 30 Jun 2021
J. Goldman & Co LP
13F
Company
13F
—
denominator unverified
$2,619,000
442,315 shares
— 30 Jun 2021
Sio Capital Management, LLC
13F
Company
13F
—
denominator unverified
$2,468,000
416,873 shares
— 30 Jun 2021
Affinity Asset Advisors, LLC
13F
Company
13F
—
denominator unverified
$2,250,000
380,000 shares
— 30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,940,000
327,658 shares
— 30 Jun 2021
Tri Locum Partners LP
13F
Company
13F
—
denominator unverified
$1,855,000
313,331 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
29
Shares
3,691,029
Rows available
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
28
Q3 2021 holders
29
Holder diff
1
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .